| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rein Therapeutics, Inc. (RNTX) has 6 insiders with recent SEC Form 4 filings, including 9 buys and 3 sells. RNTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 926.4K | $837.4K | - | |
| Dir | 17.5K | $15.8K | - | |
| Dir | 17.5K | $15.8K | - | |
| Dir | 17.5K | $15.8K | - | |
| Dir | 17.5K | $15.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 107,904 | $6.31 | $681,390.36 | -3.3% | |
| Jan 9, 2018 | Apple Tree Partners II LP | 10% Owner | Sell | 150,000 | $9.80 | $1,470,435.00 | -8.3% | |
| Jul 5, 2017 | Kapnick Scott | Director, 10% Owner | Buy | 225,973 | $15.00 | $3,389,595.00 | +30.2% | |
| Jul 5, 2017 | Aju Ib Investment Co., Ltd. | 10% Owner | Buy | 24,929 | $15.00 | $373,935.00 | +5.1% | |
| Jul 5, 2017 | Lv Management Group, LLC | Former 10% Owner | Buy | 250,000 | $15.00 | $3,750,000.00 | +29.6% | |
| Jul 5, 2017 | Shanafelt Armen | Director | Buy | 250,000 | $15.00 | $3,750,000.00 | +29.6% | |
| Jul 5, 2017 | Cvf, LLC | 10% Owner | Buy | 180,000 | $15.00 | $2,700,000.00 | +33.6% | |
| Jul 5, 2017 | Roche Holding Ltd | 10% Owner | Buy | 119,400 | $15.00 | $1,791,000.00 | +20.5% | |
| Jul 5, 2017 | Kck Ltd. | 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +44.8% | |
| Jul 5, 2017 | Satter Muneer A58 | 10% Owner | Buy | 33,333 | $15.00 | $499,995.00 | +23.0% |